$0.227
+0.007 (+3.18%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TRAW Prediction & Forecast by Similar Chart Analysis
Alphio's TRAW stock price prediction model matches the current Traws Pharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.23 (+1.86%). The 1-week path is $0.24 (+3.52%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Traws Pharma Inc Stock?
Traws Pharma Inc is not a good buy right now due to significant financial instability and negative market sentiment. The current price is $0.2271, which is down 82.92% year-to-date, indicating a severe decline in value. Additionally, the RSI is at 11.257, suggesting the stock is heavily oversold, but this could also indicate a lack of buying interest. The company has a forward P/E of 0, reflecting uncertainty about future earnings, and a gross margin of 0% in recent quarters, showing no profitability. The main risk is the delayed study for its lead flu drug, which has already caused a 28% drop in after-hours trading, highlighting the volatility and uncertainty surrounding the stock.
TRAW stock price ended at $0.23 on Friday, after rising +3.18%
Traws Pharma Inc (TRAW) last closed at $0.2271, gaining +3.18%. These facts feed the 1-day and 1-week TRAW price prediction above.
Forecast Drivers
Traws Pharma Inc (TRAW) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches TRAW, ranked by similarity.
Seasonality analysis for TRAW
Historically the probability of a positive November return for TRAW is 0.00%. March offers the highest probability of a positive month at 66.67%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for TRAW
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $1.18 | $1.37 | $1.48 | +505.02% |
| Dec 2026 | $0.90 | $1.15 | $1.17 | +405.28% |
In 2026, Traws Pharma Inc (TRAW) is projected to range from $0.90 to $1.48.
Traws Pharma Inc 2026 monthly forecast
In Nov 2026, Traws Pharma Inc is projected to average $1.37, with a low of $1.18 and high of $1.48.
In Dec 2026, Traws Pharma Inc is projected to average $1.15, with a low of $0.90 and high of $1.17.
Related articles
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.